Department of Gastrointestinal Surgical Oncology, Tata Memorial Hospital, Parel, Mumbai, India.
HPB (Oxford). 2008;10(1):43-7. doi: 10.1080/13651820701867794.
There is a need to increase the available data on revision radical surgery for incidental gallbladder cancer and to determine factors influencing operability. We aimed to assess the impact of stage of disease (pT) and the type of primary surgery (laparoscopy versus open) on resectability rates.
The data of 90 consecutive patients referred to the Tata Memorial Hospital between 1 January 2003 and 30 April 2007 for revision radical surgery for incidental gallbladder cancer were reviewed retrospectively.
Of the 90 patients who underwent revision surgery, accurate data on T-stage was available in 76, and of these 76 patients, 44 (57.8%) had prior laparoscopic simple cholecystectomy, while 32 (42.2%) had undergone open surgery. The median time interval between the two surgeries was 2 months (range 4 weeks to 11 months). By T-stage, 23 patients had T1b disease, while 33 and 20 patients had T2 and T3 disease, respectively. Successful revision surgery could be undertaken in 71% of patients (54/76) and 29.6% of these had residual disease confirmed by histopathological examination.
T-stage is an important factor in determining operability as confirmed by our study. As the T-stage of the disease increased, the chances of finding residual disease increased, while operability decreased. Furthermore, the case for revision surgery is strengthened because the incidence of lymph nodal disease is high even for pT1b cancers. The type of primary surgery does not affect operability in patients undergoing revision radical surgery for incidental gallbladder cancer.
需要增加关于偶然胆囊癌的修正根治性手术的可用数据,并确定影响可操作性的因素。我们旨在评估疾病分期(pT)和主要手术类型(腹腔镜与开腹)对可切除性的影响。
回顾性分析了 2003 年 1 月 1 日至 2007 年 4 月 30 日期间,因偶然胆囊癌在塔塔纪念医院接受修正根治性手术的 90 例连续患者的数据。
在接受修正手术的 90 例患者中,76 例有准确的 T 分期数据,其中 44 例(57.8%)之前接受过腹腔镜单纯胆囊切除术,32 例(42.2%)接受过开腹手术。两次手术之间的中位时间间隔为 2 个月(范围 4 周至 11 个月)。按 T 分期,23 例患者为 T1b 期,33 例和 20 例患者分别为 T2 和 T3 期。71%(54/76)的患者可成功进行修正手术,其中 29.6%的患者通过组织病理学检查证实有残留疾病。
T 分期是确定可操作性的重要因素,正如我们的研究证实的那样。随着疾病 T 分期的增加,发现残留疾病的可能性增加,而可操作性降低。此外,即使对于 pT1b 癌症,淋巴结疾病的发生率也很高,因此修正手术的理由更为充分。对于因偶然胆囊癌接受修正根治性手术的患者,原发手术类型不影响可操作性。